Cleared Traditional

K161959 - ClearView cCAD

K161959 is an FDA 510(k) clearance for ClearView cCAD, manufactured by Clearview Diagnostics, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 163-day FDA review.

K161959 · Clearview Diagnostics, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2016
Decision
163d
Days
Class 2
Risk

K161959 is an FDA 510(k) clearance for the ClearView cCAD. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Clearview Diagnostics, Inc. (Piscataway, US). The FDA issued a Cleared decision on December 28, 2016 after a review of 163 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Clearview Diagnostics, Inc. devices

FDA 510(k) Submission Details - K161959

510(k) Number K161959 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2016
Decision Date December 28, 2016
Days to Decision 163 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
56d slower than avg
Panel avg: 107d · This submission: 163d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1236
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K161959.
Multi Modality Viewer
K163574 · Vital Images, Inc. · Jan 2017
EzDent-i
K163533 · Ewoosoft Co., Ltd. · Jan 2017
syngo.via MI Workflows
K163421 · Siemens Medical Solutions USA, Inc. · Jan 2017
Ez3D-i / E3
K163539 · Ewoosoft Co., Ltd. · Dec 2016
Multi-Modality Tumor Tracking (MMTT) application
K162955 · Philips Medical Systems Nederland B.V. · Dec 2016
CAAS MR 4D Flow
K162376 · Pie Medical Imaging BV · Dec 2016